{"title": "Peer-reviewed Journal: PEG immunogenicity and vaccine safety", "author": "CAS Science Team", "url": "https://www.cas.org/resources/cas-insights/emerging-science/peer-reviewed-journal-peg-immunogenicity-and-vaccine-safety", "hostname": "cas.org", "description": "This peer-reviewed journal publication in Bioconjugate Chemistry shows how PEGylated lipid nanoparticles are used to deliver mRNA vaccines and other drugs, the immunogenicity concerns with vaccines, and emerging approaches on new designs to increase efficacy and safety.", "sitename": "CAS", "date": "2023-05-26", "cleaned_text": "Lipid nanoparticles have redefined what's possible in drug delivery, from recent acclaim in COVID-19 vaccines to a storied history of novel drug delivery mechanisms. However, it may come with a price: immune reactions that can compromise the safety and efficacy of PEGylated lipid nanoparticles. With a clinical pipeline full of exciting new RNA therapeutics, how can we overcome this? Learn more about the emerging trends, opportunities, and challenges in our latest peer-reviewed "}